- $93.67bn
- $96.44bn
- $4.71bn
Annual income statement for Applovin, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,451 | 2,793 | 2,817 | 3,283 | 4,709 |
Cost of Revenue | |||||
Gross Profit | 896 | 1,805 | 1,689 | 2,224 | 3,542 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,513 | 2,660 | 2,865 | 2,639 | 2,864 |
Operating Profit | -62 | 133 | -47.8 | 644 | 1,845 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -136 | 46.3 | -205 | 381 | 1,576 |
Provision for Income Taxes | |||||
Net Income After Taxes | -126 | 35.3 | -193 | 357 | 1,580 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -125 | 35.4 | -193 | 357 | 1,580 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -125 | 31.9 | -193 | 355 | 1,577 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.185 | 0.168 | 0.14 | 0.999 | 4.63 |
Dividends per Share |